Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries

Author： Liu Bao Peng   Chong Qing Tan   Xiao Min Wan   Cui Wei  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.7, 2007-01, pp. : 619-619

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study

By Knapp Martin   Windmeijer Frank  

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 341-358

Adis International

Access to resources Recommend Favorite

Cost-benefit or cost-utility analysis?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Discounting in Cost-Utility Analysis of Healthcare Interventions: Reassessing Current Practice

By Cohen B.J.  

PharmacoEconomics, Vol. 21, Iss. 2, 2003-01 ,pp. : 75-87

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

By Igarashi Ataru  

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 247-261

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological Approach

By Vanagas Giedrius   Padaiga Zilvinas   Bagdonas Eugenijus  

Substance Use & Misuse, Vol. 41, Iss. 1, 2006-06 ,pp. : 87-101

Informa Healthcare

Access to resources Recommend Favorite